Meningoencephalitis Panel with Reflex to Herpes Simplex Virus Types 1 and 2 Glycoprotein G-Specific Antibodies, IgG, Serum
2008918
 
Ordering Recommendation
Mnemonic
MENINGO
Methodology
Semi-Quantitative Enzyme-Linked Immunosorbent Assay/Semi-Quantitative Indirect Fluorescent Antibody/Semi-Quantitative Chemiluminescent Immunoassay
Performed
Sun-Sat
Reported
2-6 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Serum separator tube.  
Specimen Preparation
Transfer 3 mL serum to an ARUP Standard Transport Tube. (Min: 2 mL)  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
CSF. Contaminated, heat-inactivated, hemolyzed, or icteric specimens. CSF (refer to Meningoencephalitis Panel with Reflex to Herpes Simplex Virus Types 1 and 2 Glycoprotein G-Specific Antibodies, IgG, CSF, test code 2008917).  
Remarks
 
Stability
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year  
Reference Interval
Test Number Components Reference Interval
0050508California Encephalitis Antibody, IgG by IFA, Serum Less than 1:16
0098731California Encephalitis Antibody, IgM by IFA, Serum Less than 1:16
0050509Eastern Equine Encephalitis Antibody, IgG by IFA, Serum Less than 1:16
0098733Eastern Equine Encephalitis Antibody, IgM by IFA, Serum Less than 1:16
0050507St. Louis Encephalitis Antibody, IgG by IFA, Serum Less than 1:16
0098732St. Louis Encephalitis Antibody, IgM by IFA, Serum Less than 1:16
0050514Western Equine Encephalitis Antibody, IgG by IFA, Serum Less than 1:16
0098734Western Equine Encephalitis Antibody, IgM by IFA, Serum Less than 1:16
0050234West Nile Virus Antibody, IgG by ELISA, Serum 1.29 IV or less: Negative -​ No significant level of West Nile virus IgG antibody detected.
1.30-​1.49 IV: Equivocal -​ Questionable presence of West Nile virus IgG antibody detected. Repeat testing in 10-​14 days may be helpful.
1.50 IV or greater: Positive -​ Presence of IgG antibody to West Nile virus detected, suggestive of current or past infection.
0050236West Nile Virus Antibody, IgM by ELISA, Serum 0.89 IV or less: Negative -​ No significant level of West Nile virus IgM antibody detected.
0.90-​1.10 IV: Equivocal -​ Questionable presence of West Nile virus IgM antibody detected. Repeat testing in 10-​14 days may be helpful.
1.11 IV or greater: Positive -​ Presence of IgM antibody to West Nile virus detected, suggestive of current or recent infection.
0050380Measles (Rubeola) Antibody, IgG Effective August 20, 2012

24.9 AU/mL or less: Negative -​ No significant level of detectable measles (rubeola) IgG antibody.
25.0-​29.9 AU/mL: Equivocal -​ Repeat testing in 10-​14 days may be helpful.
30.0 AU/mL or greater: Positive -​ IgG antibody to measles (rubeola) detected, which may indicate a current or past exposure/immunization to measles (rubeola).
0099597Measles (Rubeola) Antibody, IgM 0.79 AU or less: Negative -​ No significant level of IgM antibodies to measles (rubeola) virus detected.
0.80-​1.20 AU: Equivocal -​ Repeat testing in 10-​14 days may be helpful.
1.21 AU or greater: Positive -​ IgM antibodies to measles (rubeola) virus detected. Suggestive of current or recent infection or immunization. However, low levels of IgM antibodies may occasionally persist for more than 12 months post-​infection or immunization.
0050390Mumps Virus Antibody, IgG Effective August 20, 2012

8.9 AU/mL or less: Negative -​ No significant level of detectable IgG mumps virus antibody.
9.0-​10.9 AU/mL: Equivocal -​ Repeat testing in 10-​14 days may be helpful.
11.0 AU/mL or greater: Positive -​ IgG antibody to mumps virus detected, which may indicate a current or past exposure/immunization to mumps virus.
0099589Mumps Virus Antibody, IgM 0.79 IV or less: Negative -​ No significant level of detectable IgM antibody to Mumps virus.
0.80-​1.20 IV: Equivocal -​ Borderline levels of IgM antibody to Mumps virus. Repeat testing in 10-​14 days may be helpful.
1.21 IV or greater: Positive -​ Presence of IgM antibody to Mumps virus detected, which may indicate a current or recent infection. However, low levels of IgM antibody may occasionally persist for more than 12 months post-​infection or immunization.
0050167Varicella-​Zoster Virus Antibody, IgG Effective August 20, 2012

134 IV or less: Negative -​ No significant level of detectable varicella-​zoster IgG antibody.
135-​165 IV: Equivocal -​ Repeat testing in 10-​14 days may be helpful.
166 IV or greater: Positive -​ IgG antibody to varicella-​zoster detected, which may indicate a current or past varicella-​zoster infection.
0099314Varicella-​Zoster Virus Antibody, IgM 0.90 ISR or less: Negative -​ No significant level of detectable varicella-​zoster virus IgM antibody.
0.91-​1.09 ISR: Equivocal -​ Repeat testing in 10-​14 days may be helpful.
1.10 ISR or greater: Positive -​ Significant level of detectable varicella-​zoster virus IgM antibody. Indicative of current or recent infection. However, low levels of IgM antibodies may occasionally persist for more than 12 months post-​infection or immunization.
0050641Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgM by ELISA
0.89 IV or less: Not Detected.
0.90-​1.09 IV: Indeterminate -​ Repeat testing in 10-​14 days may be helpful.
1.10 IV or greater: Detected -​ IgM antibody to HSV detected, which may indicate a current or recent infection. However, low levels of IgM antibodies may occasionally persist for more than 12 months post-​infection.
0050293Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgG
0.89 IV or less: Not Detected.
0.90-​1.09 IV: Indeterminate -​ Repeat testing in 10-​14 days may be helpful.
1.10 IV or greater: Detected.
0050292Herpes Simplex Virus Type 1 Glycoprotein G-​Specific Antibody, IgG by CIA
Effective February 18, 2014
0.90 IV or less Negative -​ No significant level of detectable IgG antibody to HSV type 1 glycoprotein G.
0.91-​1.09 IV Equivocal -​ Questionable presence of IgG antibody to HSV type 1 glycoprotein G. Repeat testing in 10-​14 days may be helpful.
1.10 IV or greater Positive -​ IgG antibody to HSV type 1 glycoprotein G detected, which may indicate a current or past HSV infection.
0050294Herpes Simplex Virus Type 2 Glycoprotein G-​Specific Antibody, IgG by CIA
Effective February 18, 2014
0.90 IV or less Negative -​ No significant level of detectable IgG antibody to HSV type 2 glycoprotein G.
0.91-​1.09 IV Equivocal -​ Questionable presence of IgG antibody to HSV type 2 glycoprotein G. Repeat testing in 10-​14 days may be helpful.
1.10 IV or greater Positive -​ IgG antibody to HSV type 2 glycoprotein G detected, which may indicate a current or past HSV infection.
Interpretive Data
Refer to individual components for additional Interpretive Data.
Note
If HSV 1 and/or 2 IgG is 1.10 IV or greater, then HSV 1 G-Specific IgG and HSV 2 G-Specific IgG will be added. Additional charges apply.
CPT Code(s)
86651 x2; 86652 x2; 86653 x2; 86654 x2; 86789; 86788; 86765 x2; 86735 x2; 86787 x2; 86694; 86694; if reflexed, add 86695; 86696
Components
Component Test Code*Component Chart Name
0050167Varicella-Zoster Virus Ab, IgG
0050234West Nile Virus Ab, IgG, Ser
0050236West Nile Virus Ab, IgM, Ser
0050286HSV Type 1/2 Combined Ab, IgG
0050380Measles, Rubeola, Antibody IgG
0050390Mumps Virus Antibody, IgG
0050507St. Louis Encephalitis Ab, IgG, Serum
0050508Calif Encephalitis Antibody IgG
0050509Eastern Equine Enceph Ab, IgG
0050514Western Equine Enceph Ab, IgG, Serum
0050641HSV 1 and/or 2 Abs, IgM by ELISA
0098731California Encephalitis IgM
0098732St. Louis Encephalitis Ab, IgM, Serum
0098733Eastern Equine Enceph Ab, IgM
0098734Western Equine Enceph Ab, IgM, Ser
0099314Varicella-Zoster Virus Antibody, IgM
0099589Mumps Virus Antibody, IgM
0099597Measles, Rubeola, Antibody IgM
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at interface.support@aruplab.com.
Cross References